Publications
Specialty
Search
Vascular Disease Management, CardioVascular
06/17/2024
Failure of an SBVCD is an independent predictor of vascular complications and a leading cause of morbidity. This collection of cases illustrates the failure of SBVCDs, including the associated challenges, management strategies, and outcomes.
Rheumatology & Arthritis
06/17/2024
The European Alliance of Associations for Rheumatology (EULAR) updated its 2019 guideline for the management of psoriatic arthritis to integrate new data and therapies.
Oncology
06/17/2024
Based on results from the phase 3 DUO-E trial, the FDA has approved durvalumab plus carboplatin and paclitaxel followed by durvalumab maintenance for patients with primary advanced or recurrent mismatch repair deficient endometrial cancer.
ePlasty, Surgery
06/17/2024
This Case Q&A discusses latissimus dorsi free flaps as a reconstructive option for the management of acquired abdominal wall defects.
Oncology
06/17/2024
According to results from the phase 3 PEARLY trial, the addition of carboplatin to standard anthracycline and taxane therapy significantly improved event-free survival among patients with early-stage triple-negative breast cancer.
Oncology
06/17/2024
In this video, a panel of experts discuss the sequencing of antibody drug conjugates of patients with HER2-low metastatic breast cancer, including trastuzumab deruxtecan, sacituzumab govitecan, and datopotamab deruxtecan.
Journal of Clinical Pathways
06/17/2024
Paul Fu Jr, MD, MPH, discusses the benefits of using technology to assist health team communication practices.
Cancer Care Business Exchange, Journal of Clinical Pathways, Clinical Pathways
06/17/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the process of drug approvals and the role of the US Food and Drug Administration, including how and why the process takes so much time—and can add to the cost of treatments once they hit the market.
The Dermatologist
06/17/2024
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Advances in Inflammatory Bowel Disease Network
06/17/2024
Dr Panaccione reviews the results of the GALAXI 2 and 3 trials of guselkumab for treatment of Crohn's disease, which he presented at Digestive Disease Week 2024.
The Dermatologist
06/16/2024
A recent update from the GLOBOSTAD study offered valuable insights into the real-world effectiveness of dupilumab, a promising treatment for atopic dermatitis.
The Dermatologist
06/15/2024
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
The Dermatologist
06/15/2024
The US Food and Drug Administration has approved a new Adbry (tralokinumab-ldrm) 300 mg single-dose autoinjector, offering a new administration option for adult patients with moderate-to-severe atopic dermatitis.
Vascular Disease Management, CardioVascular
06/15/2024
VDM spoke with vascular surgeon Jayer Chung, MD, about treating patients with acute limb ischemia with Penumbra’s computer assisted vacuum thrombectomy technology such as Lightning Bolt™ 7 System to remove thrombus.
EMSWorld
06/14/2024
Drowning incidents can be life-threatening, but does the type of water significantly affect treatment?
The Dermatologist
06/14/2024
In this interview, Dr Ramone F. Williams discusses the Mohs Surgeons Leading the Future program and highlights the program's objectives, the specific projects undertaken, and the valuable lessons learned by participants in enhancing their leadership skills and advancing the field of Mohs surgery.
EP Lab Digest
06/14/2024
Company Committed to TEECAD for Use with Smaller Transesophageal Echocardiography (TEE) Probes
Neurology
06/14/2024
Refresh your knowledge of a common sleep disorder with this quiz!
Rheumatology & Arthritis
06/14/2024
A composite measure of disease activity in axial spondyloarthritis that includes extra-articular manifestations could provide more accurate assessments, researchers say.
Vascular Disease Management, CardioVascular, Journal of Invasive Cardiology
06/14/2024
OPELOUSAS, LA – Dr. Kalyan Veerina, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Acadiana and second in Louisiana to use the Paradise® Ultrasound Renal Denervation (RDN) System, a new first-of-its-kind treatment option for patients with high blood pressure. The procedure took place at Opelousas General Health System (OGHS).